Walleye Capital
PRCT icon

Walleye Capital’s Procept Biorobotics PRCT Stock Holding History

Walleye Capital’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$192K Buy
+8,500
New +$213K ﹤0.01% 3528
2026
Q1 		– Sell
-17,000
Closed -$535K – 4850
2025
Q4 		$535K Buy
17,000
+6,500
+62% +$216K ﹤0.01% 2923
2025
Q3 		$375K Buy
10,500
+8,500
+425% +$388K ﹤0.01% 2832
2025
Q2 		$115K Sell
2,000
-400
-17% -$22.6K ﹤0.01% 3704
2025
Q1 		$140K Buy
2,400
+700
+41% +$47.8K ﹤0.01% 3466
2024
Q4 		$137K Buy
1,700
+300
+21% +$25.6K ﹤0.01% 3975
2024
Q3 		$112K Sell
1,400
-9,300
-87% -$661K ﹤0.01% 4351
2024
Q2 		$654K Buy
10,700
+4,300
+67% +$256K ﹤0.01% 3263
2024
Q1 		$316K Buy
+6,400
New +$305K ﹤0.01% 3619

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Walleye Capital's PRCT Position: Q2 2026 in Review

Walleye Capital opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 532 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #4475 among its holdings. This is a return to the name: Walleye Capital previously reported a position in PRCT as recently as Q3 2025.

Walleye Capital first reported a position in PRCT in Q4 2023 and has held it in 7 quarters since. The position peaked at $2.77M in Q2 2024. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Walleye Capital held 532 shares of Procept Biorobotics worth $12K as of Q2 2026.
  • Procept Biorobotics was a new Walleye Capital position in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4475 holding.
  • Walleye Capital first reported a position in Procept Biorobotics in Q4 2023 and has held it in 7 quarters since.
  • Walleye Capital's Procept Biorobotics position peaked at $2.77M in Q2 2024.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.